News | March 02, 2026
Moderna wins EU backing for world’s first combined flu-COVID shot
The decision marks a pivotal moment for the Massachusetts-based biotech giant
The decision marks a pivotal moment for the Massachusetts-based biotech giant
Iza-bren met both dual primary endpoints, delivering statistically significant and clinically meaningful improvements in progression-free survival
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
The facility is expected to become operational by FY2028-29
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Subscribe To Our Newsletter & Stay Updated
